-
1
-
-
79952232216
-
Global cancer statistics
-
PID: 21296855
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
77952300630
-
Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution
-
House MG, Ito H, Gonen M, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010;210:744-52–752-45.
-
(2010)
J Am Coll Surg
, vol.210
, pp. 744-52-752-45
-
-
House, M.G.1
Ito, H.2
Gonen, M.3
-
3
-
-
68949094312
-
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy
-
PID: 19470929
-
Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27:3677–83.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3677-3683
-
-
Kopetz, S.1
Chang, G.J.2
Overman, M.J.3
-
4
-
-
84883680951
-
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer
-
COI: 1:CAS:528:DC%2BC3sXhsFGktr3L, PID: 24024839
-
Douillard JY, Oliner KS, Siena S, et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013;369:1023–34.
-
(2013)
N Engl J Med
, vol.369
, pp. 1023-1034
-
-
Douillard, J.Y.1
Oliner, K.S.2
Siena, S.3
-
5
-
-
84937143954
-
Metastatic colorectal cancer: current state and future directions
-
COI: 1:CAS:528:DC%2BC2MXht1eisb3L, PID: 25918280
-
Fakih MG. Metastatic colorectal cancer: current state and future directions. J Clin Oncol. 2015;33:1809–24.
-
(2015)
J Clin Oncol
, vol.33
, pp. 1809-1824
-
-
Fakih, M.G.1
-
6
-
-
68849110472
-
Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer
-
COI: 1:CAS:528:DC%2BD1MXht1Wns7vN, PID: 19474002
-
Seth R, Crook S, Ibrahem S, Fadhil W, Jackson D, Ilyas M. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer. Gut. 2009;58:1234–41.
-
(2009)
Gut
, vol.58
, pp. 1234-1241
-
-
Seth, R.1
Crook, S.2
Ibrahem, S.3
Fadhil, W.4
Jackson, D.5
Ilyas, M.6
-
7
-
-
84939251514
-
Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases
-
COI: 1:CAS:528:DC%2BC2MXhtlWiu7zJ, PID: 26206254
-
Brudvik KW, Kopetz SE, Li L, Conrad C, Aloia TA, Vauthey JN. Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases. Br J Surg. 2015;102:1175–83.
-
(2015)
Br J Surg
, vol.102
, pp. 1175-1183
-
-
Brudvik, K.W.1
Kopetz, S.E.2
Li, L.3
Conrad, C.4
Aloia, T.A.5
Vauthey, J.N.6
-
8
-
-
84918824615
-
KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases
-
COI: 1:CAS:528:DC%2BC2cXitVaqsLvJ, PID: 25155157
-
Kemeny NE, Chou JF, Capanu M, et al. KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases. Cancer. 2014;120:3965–71.
-
(2014)
Cancer
, vol.120
, pp. 3965-3971
-
-
Kemeny, N.E.1
Chou, J.F.2
Capanu, M.3
-
9
-
-
84947127636
-
Effect of KRAS mutation on long-term outcomes of patients undergoing hepatic resection for colorectal liver metastases
-
PID: 26077912
-
Margonis GA, Spolverato G, Kim Y, Karagkounis G, Choti MA, Pawlik TM. Effect of KRAS mutation on long-term outcomes of patients undergoing hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2015;22:4158–65.
-
(2015)
Ann Surg Oncol
, vol.22
, pp. 4158-4165
-
-
Margonis, G.A.1
Spolverato, G.2
Kim, Y.3
Karagkounis, G.4
Choti, M.A.5
Pawlik, T.M.6
-
10
-
-
84884493477
-
RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases
-
PID: 24018645
-
Vauthey JN, Zimmitti G, Kopetz SE, et al. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg. 2013;258:619–26.
-
(2013)
Ann Surg
, vol.258
, pp. 619-626
-
-
Vauthey, J.N.1
Zimmitti, G.2
Kopetz, S.E.3
-
11
-
-
0035098522
-
Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases
-
COI: 1:STN:280:DC%2BD3M7osFWksA%3D%3D, PID: 11237496
-
Petrowsky H, Sturm I, Graubitz O, et al. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases. Eur J Surg Oncol. 2001;27:80–7.
-
(2001)
Eur J Surg Oncol
, vol.27
, pp. 80-87
-
-
Petrowsky, H.1
Sturm, I.2
Graubitz, O.3
-
12
-
-
84870670197
-
Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma
-
COI: 1:CAS:528:DC%2BC38XhslKrur%2FN, PID: 22674181
-
Rose JS, Serna DS, Martin LK, et al. Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma. Cancer. 2012;118:6243–52.
-
(2012)
Cancer
, vol.118
, pp. 6243-6252
-
-
Rose, J.S.1
Serna, D.S.2
Martin, L.K.3
-
13
-
-
84863722109
-
BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy
-
COI: 1:CAS:528:DC%2BC38XpvVehsrk%3D, PID: 22331825
-
Teng HW, Huang YC, Lin JK, et al. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy. J Surg Oncol. 2012;106:123–9.
-
(2012)
J Surg Oncol
, vol.106
, pp. 123-129
-
-
Teng, H.W.1
Huang, Y.C.2
Lin, J.K.3
-
14
-
-
0033788456
-
Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes’ C colon cancer
-
COI: 1:CAS:528:DC%2BD3cXotVOhtLw%3D, PID: 11051374
-
Bleeker WA, Hayes VM, Karrenbeld A, et al. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes’ C colon cancer. Am J Gastroenterol. 2000;95:2953–7.
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 2953-2957
-
-
Bleeker, W.A.1
Hayes, V.M.2
Karrenbeld, A.3
-
15
-
-
84930804509
-
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
-
COI: 1:STN:280:DC%2BC2MfksVGhug%3D%3D, PID: 25979833
-
Brule SY, Jonker DJ, Karapetis CS, et al. Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17. Eur J Cancer. 2015;51:1405–14.
-
(2015)
Eur J Cancer
, vol.51
, pp. 1405-1414
-
-
Brule, S.Y.1
Jonker, D.J.2
Karapetis, C.S.3
-
16
-
-
0025048761
-
Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location
-
COI: 1:STN:280:DyaK3M%2Flt1Olug%3D%3D, PID: 2240880
-
Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990;113:779–88.
-
(1990)
Ann Intern Med
, vol.113
, pp. 779-788
-
-
Bufill, J.A.1
-
17
-
-
84922887961
-
Is right-sided colon cancer different to left-sided colorectal cancer? A systematic review
-
COI: 1:STN:280:DC%2BC2MzksVCisg%3D%3D, PID: 25468456
-
Lee GH, Malietzis G, Askari A, Bernardo D, Al-Hassi HO, Clark SK. Is right-sided colon cancer different to left-sided colorectal cancer? A systematic review. Eur J Surg Oncol. 2015;41:300–8.
-
(2015)
Eur J Surg Oncol
, vol.41
, pp. 300-308
-
-
Lee, G.H.1
Malietzis, G.2
Askari, A.3
Bernardo, D.4
Al-Hassi, H.O.5
Clark, S.K.6
-
18
-
-
40349100700
-
Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology
-
PID: 17532785
-
Nawa T, Kato J, Kawamoto H, et al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol. 2008;23:418–23.
-
(2008)
J Gastroenterol Hepatol
, vol.23
, pp. 418-423
-
-
Nawa, T.1
Kato, J.2
Kawamoto, H.3
-
19
-
-
84955572772
-
Right sided colon cancer as a distinct histopathological subtype with reduced prognosis
-
PID: 26824772
-
Nitsche U, Stogbauer F, Spath C, et al. Right sided colon cancer as a distinct histopathological subtype with reduced prognosis. Dig Surg. 2016;33:157–63.
-
(2016)
Dig Surg
, vol.33
, pp. 157-163
-
-
Nitsche, U.1
Stogbauer, F.2
Spath, C.3
-
20
-
-
84922536963
-
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
-
COI: 1:STN:280:DC%2BC2cbltleksg%3D%3D, PID: 25057166
-
Missiaglia E, Jacobs B, D’Ario G, et al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol. 2014;25:1995–2001.
-
(2014)
Ann Oncol
, vol.25
, pp. 1995-2001
-
-
Missiaglia, E.1
Jacobs, B.2
D’Ario, G.3
-
22
-
-
84908339502
-
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial
-
von Einem JC, Heinemann V, von Weikersthal LF, et al. Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial. J Cancer Res Clin Oncol. 2014;140:1607–14.
-
(2014)
J Cancer Res Clin Oncol
, vol.140
, pp. 1607-1614
-
-
von Einem, J.C.1
Heinemann, V.2
von Weikersthal, L.F.3
-
23
-
-
84884666514
-
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
-
PID: 24073892
-
Popovici V, Budinska E, Bosman FT, Tejpar S, Roth AD, Delorenzi M. Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer. BMC Cancer. 2013;13:439.
-
(2013)
BMC Cancer
, vol.13
, pp. 439
-
-
Popovici, V.1
Budinska, E.2
Bosman, F.T.3
Tejpar, S.4
Roth, A.D.5
Delorenzi, M.6
-
24
-
-
84930811951
-
Different treatment strategies and molecular features between right-sided and left-sided colon cancers
-
COI: 1:CAS:528:DC%2BC2MXhs1SgurvL, PID: 26074686
-
Shen H, Yang J, Huang Q, et al. Different treatment strategies and molecular features between right-sided and left-sided colon cancers. World J Gastroenterol. 2015;21:6470–8.
-
(2015)
World J Gastroenterol
, vol.21
, pp. 6470-6478
-
-
Shen, H.1
Yang, J.2
Huang, Q.3
-
25
-
-
84879685038
-
Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability
-
PID: 23010994
-
Umeda Y, Nagasaka T, Mori Y, et al. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability. J Hepatobiliary Pancreat Sci. 2013;20:223–33.
-
(2013)
J Hepatobiliary Pancreat Sci
, vol.20
, pp. 223-233
-
-
Umeda, Y.1
Nagasaka, T.2
Mori, Y.3
-
26
-
-
63849088630
-
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer
-
PID: 19339720
-
Van Cutsem E, Kohne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360:1408–17.
-
(2009)
N Engl J Med
, vol.360
, pp. 1408-1417
-
-
Van Cutsem, E.1
Kohne, C.H.2
Hitre, E.3
-
27
-
-
79956298812
-
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status
-
PID: 21502544
-
Van Cutsem E, Kohne CH, Lang I, et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol. 2011;29:2011–9.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2011-2019
-
-
Van Cutsem, E.1
Kohne, C.H.2
Lang, I.3
-
28
-
-
0033504042
-
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases
-
COI: 1:STN:280:DyaK1MvitFahsw%3D%3D, PID: 10493478
-
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–18.
-
(1999)
Ann Surg
, vol.230
, pp. 309-318
-
-
Fong, Y.1
Fortner, J.2
Sun, R.L.3
Brennan, M.F.4
Blumgart, L.H.5
-
29
-
-
84937816541
-
Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy
-
COI: 1:CAS:528:DC%2BC2cXitFKltbbM, PID: 25532759
-
Maus MK, Hanna DL, Stephens CL, et al. Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. Pharmacogenomics J. 2015;15:354–62.
-
(2015)
Pharmacogenomics J
, vol.15
, pp. 354-362
-
-
Maus, M.K.1
Hanna, D.L.2
Stephens, C.L.3
-
30
-
-
0036242782
-
CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability
-
COI: 1:CAS:528:DC%2BD38Xkt1Cru7s%3D, PID: 11984524
-
Hawkins N, Norrie M, Cheong K, et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology. 2002;122:1376–87.
-
(2002)
Gastroenterology.
, vol.122
, pp. 1376-1387
-
-
Hawkins, N.1
Norrie, M.2
Cheong, K.3
-
31
-
-
0036895068
-
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
-
PID: 12427779
-
van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, Iacopetta B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut. 2002;51:797–802.
-
(2002)
Gut.
, vol.51
, pp. 797-802
-
-
van Rijnsoever, M.1
Grieu, F.2
Elsaleh, H.3
Joseph, D.4
Iacopetta, B.5
-
32
-
-
16644376564
-
Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases
-
PID: 15525826
-
Haddad R, Ogilvie RT, Croitoru M, et al. Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases. Ann Surg Oncol. 2004;11:977–82.
-
(2004)
Ann Surg Oncol.
, vol.11
, pp. 977-982
-
-
Haddad, R.1
Ogilvie, R.T.2
Croitoru, M.3
-
33
-
-
58749102767
-
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
-
COI: 1:CAS:528:DC%2BD1MXpsVSrsQ%3D%3D, PID: 19165197
-
Koopman M, Kortman GA, Mekenkamp L, et al. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer. 2009;100:266–73.
-
(2009)
Br J Cancer.
, vol.100
, pp. 266-273
-
-
Koopman, M.1
Kortman, G.A.2
Mekenkamp, L.3
|